Puma's Auerbach Gains on Pfizer Retreat From Breast Cancer Drug

Home › Puma's Auerbach Gains on Pfizer Retreat From Breast Cancer Drug

Alan Auerbach specializes in testing drugs that Big Pharma doesn't want anymore, and that has made him a billionaire.

25.06	Royal Mail buyer to make offer for all staff shares
25.06	Hybrid Software wins FLAG Vendor Partner of the Year award
25.06	Hospeco Purchases Nuance Solutions
25.06	Atlantic Tropical Weather Outlook
25.06	DNA Genetics opens new commercial sow research farm
25.06	Eastern North Pacific Tropical Weather Outlook
25.06	Briolf Group to Invest $30 Million in Its First US Production Plant
25.06	IDENTCO rebrands TTL200 Series to DuraWrap and DuraFlag
More »

je.st